KARO.ST
Karo Pharma AB
Price:  
60.30 
SEK
Volume:  
7,820.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KARO.ST WACC - Weighted Average Cost of Capital

The WACC of Karo Pharma AB (KARO.ST) is 5.9%.

The Cost of Equity of Karo Pharma AB (KARO.ST) is 6.50%.
The Cost of Debt of Karo Pharma AB (KARO.ST) is 5.00%.

Range Selected
Cost of equity 5.40% - 7.60% 6.50%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.0% - 6.7% 5.9%
WACC

KARO.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.37 0.51
Additional risk adjustments 1.0% 1.5%
Cost of equity 5.40% 7.60%
Tax rate 20.60% 20.90%
Debt/Equity ratio 0.35 0.35
Cost of debt 5.00% 5.00%
After-tax WACC 5.0% 6.7%
Selected WACC 5.9%